Konkurencja i konsument · 17/01/1997
Fresenius AG to Divest Hemodialysis Concentrate Facility in Settlement with US Regulators
Fresenius AG has agreed to divest its Lewisberry, Pennsylvania hemodialysis concentrate production facility as part of a settlement with US regulators over alleged violations of federal trade laws, with the facility to be sold to either Di-Chem, Inc. or another approved acquirer.